Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Neoplasms of the CNS

  Free Subscription


06.11.2017

3 AJNR Am J Neuroradiol
1 Am J Clin Oncol
1 Cancer
6 Cancer Res
1 Childs Nerv Syst
1 Clin Cancer Res
1 Int J Cancer
1 J Neurol
13 J Neurooncol
1 J Neuropathol Exp Neurol
2 J Neurosurg
4 Neuro Oncol
1 Neuroradiology
8 Neurosurgery
4 PLoS One
1 Proc Natl Acad Sci U S A


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    AJNR Am J Neuroradiol

  1. PEPIN KM, McGee KP, Arani A, Lake DS, et al
    MR Elastography Analysis of Glioma Stiffness and IDH1-Mutation Status.
    AJNR Am J Neuroradiol. 2017 Oct 26. doi: 10.3174/ajnr.A5415.
    PubMed     Text format     Abstract available

  2. NAM JG, Kang KM, Choi SH, Lim WH, et al
    Comparison between the Prebolus T1 Measurement and the Fixed T1 Value in Dynamic Contrast-Enhanced MR Imaging for the Differentiation of True Progression from Pseudoprogression in Glioblastoma Treated with Concurrent Radiation Therapy and Temozolomide
    AJNR Am J Neuroradiol. 2017 Oct 26. doi: 10.3174/ajnr.A5417.
    PubMed     Text format     Abstract available

  3. CHAKHOYAN A, Leu K, Pope WB, Cloughesy TF, et al
    Improved Spatiotemporal Resolution of Dynamic Susceptibility Contrast Perfusion MRI in Brain Tumors Using Simultaneous Multi-Slice Echo-Planar Imaging.
    AJNR Am J Neuroradiol. 2017 Oct 26. doi: 10.3174/ajnr.A5433.
    PubMed     Text format     Abstract available


    Am J Clin Oncol

  4. BATES JE, Youn P, Peterson CR 3rd, Usuki KY, et al
    Radiotherapy for Brain Metastases From Renal Cell Carcinoma in the Targeted Therapy Era: The University of Rochester Experience.
    Am J Clin Oncol. 2017;40:439-443.
    PubMed     Text format     Abstract available


    Cancer

  5. BLUM MURPHY M, Xiao L, Patel VR, Maru DM, et al
    Pathological complete response in patients with esophageal cancer after the trimodality approach: The association with baseline variables and survival-The University of Texas MD Anderson Cancer Center experience.
    Cancer. 2017 Sep 8. doi: 10.1002/cncr.30953.
    PubMed     Text format     Abstract available


    Cancer Res

  6. KURTSDOTTER I, Topcic D, Karlen A, Singla B, et al
    SOX5/6/21 prevent oncogene-driven transformation of brain stem cells.
    Cancer Res. 2017 Jul 7. pii: canres.0704.2017.
    PubMed     Text format     Abstract available

  7. STEPANOVA DS, Semenova G, Kuo YM, Andrews AJ, et al
    An Essential Role for the Tumor-Suppressor Merlin in Regulating Fatty Acid Synthesis.
    Cancer Res. 2017;77:5026-5038.
    PubMed     Text format     Abstract available

  8. REAP E, Suryadevara CM, Batich KA, Sanchez-Perez L, et al
    Dendritic cells enhance polyfunctionality of adoptively transferred T cells which target cytomegalovirus in glioblastoma.
    Cancer Res. 2017 Nov 1. pii: canres.0469.2017.
    PubMed     Text format     Abstract available

  9. HOLLON TC, Lewis S, Pandian B, Niknafs YS, et al
    Rapid Intraoperative Diagnosis of Pediatric Brain Tumors Using Stimulated Raman Histology.
    Cancer Res. 2017 Nov 1. pii: canres.1974.2017.
    PubMed     Text format     Abstract available

  10. MIYAUCHI JT, Caponegro MD, Chen D, Choi MK, et al
    Deletion of neuropilin 1 from microglia or bone marrow-derived macrophages slows glioma progression.
    Cancer Res. 2017 Nov 2. pii: canres.1435.2017.
    PubMed     Text format     Abstract available

  11. WAITKUS MS, Pirozzi CJ, Moure CJ, Diplas BH, et al
    Adaptive evolution of the GDH2 allosteric domain promotes gliomagenesis by resolving IDH1R132H induced metabolic liabilities.
    Cancer Res. 2017 Nov 2. pii: canres.1352.2017.
    PubMed     Text format     Abstract available


    Childs Nerv Syst

  12. LOW SYY, Soh SY, Chen MW, Ng LP, et al
    DTI fusion with conventional MR imaging in intra-operative MRI suite for paediatric brainstem glioma biopsy.
    Childs Nerv Syst. 2017 Oct 24. doi: 10.1007/s00381-017-3627.
    PubMed     Text format    


    Clin Cancer Res

  13. BYRON SA, Tran NL, Halperin RF, Phillips JJ, et al
    Prospective feasibility trial for genomics-informed treatment in recurrent and progressive glioblastoma.
    Clin Cancer Res. 2017 Oct 26. pii: clincanres.0963.2017.
    PubMed     Text format     Abstract available


    Int J Cancer

  14. KOSTOPOULOU ON, Mohammad AA, Bartek J Jr, Winter J, et al
    Glucocorticoids promote a glioma stem cell-like phenotype and resistance to chemotherapy in human glioblastoma primary cells: Biological and prognostic significance.
    Int J Cancer. 2017 Oct 25. doi: 10.1002/ijc.31132.
    PubMed     Text format     Abstract available


    J Neurol

  15. BRANDNER S, Jaunmuktane Z
    Neurological update: gliomas and other primary brain tumours in adults.
    J Neurol. 2017 Nov 2. doi: 10.1007/s00415-017-8652.
    PubMed     Text format     Abstract available


    J Neurooncol

  16. AZIZI AA, Schouten-van Meeteren AYN
    Current and emerging treatment strategies for children with progressive chiasmatic-hypothalamic glioma diagnosed as infants: a web-based survey.
    J Neurooncol. 2017 Oct 25. doi: 10.1007/s11060-017-2630.
    PubMed     Text format     Abstract available

  17. SANTANGELO A, Imbruce P, Gardenghi B, Belli L, et al
    A microRNA signature from serum exosomes of patients with glioma as complementary diagnostic biomarker.
    J Neurooncol. 2017 Oct 26. doi: 10.1007/s11060-017-2639.
    PubMed     Text format     Abstract available

  18. LOPES M, Carvalho B, Vaz R, Linhares P, et al
    Influence of neutrophil-lymphocyte ratio in prognosis of glioblastoma multiforme.
    J Neurooncol. 2017 Oct 26. doi: 10.1007/s11060-017-2641.
    PubMed     Text format     Abstract available

  19. GATELY L, McLachlan SA, Philip J, Ruben J, et al
    Long-term survivors of glioblastoma: a closer look.
    J Neurooncol. 2017 Oct 27. doi: 10.1007/s11060-017-2635.
    PubMed     Text format     Abstract available

  20. DENG S, Li Y, Yi G, Lei B, et al
    Overexpression of COX7A2 is associated with a good prognosis in patients with glioma.
    J Neurooncol. 2017 Oct 27. doi: 10.1007/s11060-017-2637.
    PubMed     Text format     Abstract available

  21. LI W, Liu Y, Yang W, Han X, et al
    MicroRNA-378 enhances radiation response in ectopic and orthotopic implantation models of glioblastoma.
    J Neurooncol. 2017 Oct 28. doi: 10.1007/s11060-017-2646.
    PubMed     Text format     Abstract available

  22. HARLAND TA, Freeman JL, Davern M, McCracken DJ, et al
    Progesterone-only contraception is associated with a shorter progression-free survival in premenopausal women with WHO Grade I meningioma.
    J Neurooncol. 2017 Oct 28. doi: 10.1007/s11060-017-2656.
    PubMed     Text format     Abstract available

  23. MASALHA W, Heiland DH, Franco P, Delev D, et al
    Atypical meningioma: progression-free survival in 161 cases treated at our institution with surgery versus surgery and radiotherapy.
    J Neurooncol. 2017 Oct 28. doi: 10.1007/s11060-017-2634.
    PubMed     Text format     Abstract available

  24. PROTOPAPA M, Zygogianni A, Stamatakos GS, Antypas C, et al
    Clinical implications of in silico mathematical modeling for glioblastoma: a critical review.
    J Neurooncol. 2017 Oct 28. doi: 10.1007/s11060-017-2650.
    PubMed     Text format     Abstract available

  25. ALTUNDAG K
    Prognostic effect of neutrophil-lymphocyte ratio during concurrrent chemo-radiotherapy period in glioblastoma patients who did not receive dexamethasone.
    J Neurooncol. 2017 Oct 31. doi: 10.1007/s11060-017-2645.
    PubMed     Text format    

  26. HAQUE W, Verma V, Butler EB, Teh BS, et al
    Addition of chemotherapy to hypofractionated radiotherapy for glioblastoma: practice patterns, outcomes, and predictors of survival.
    J Neurooncol. 2017 Oct 31. doi: 10.1007/s11060-017-2654.
    PubMed     Text format     Abstract available

  27. FUJIMOTO D, von Eyben R, Gibbs IC, Chang SD, et al
    Imaging changes over 18 months following stereotactic radiosurgery for brain metastases: both late radiation necrosis and tumor progression can occur.
    J Neurooncol. 2017 Nov 2. doi: 10.1007/s11060-017-2647.
    PubMed     Text format     Abstract available

  28. MCCULLOUGH BJ, Ader V, Aguedan B, Feng X, et al
    Preoperative relative cerebral blood volume analysis in gliomas predicts survival and mitigates risk of biopsy sampling error.
    J Neurooncol. 2017 Nov 2. doi: 10.1007/s11060-017-2642.
    PubMed     Text format     Abstract available


    J Neuropathol Exp Neurol

  29. SHI QY, Feng X, Bao W, Ma J, et al
    MYC/BCL2 Co-Expression Is a Stronger Prognostic Factor Compared With the Cell-of-Origin Classification in Primary CNS DLBCL.
    J Neuropathol Exp Neurol. 2017;76:942-948.
    PubMed     Text format     Abstract available


    J Neurosurg

  30. KIESEL B, Mischkulnig M, Woehrer A, Martinez-Moreno M, et al
    Systematic histopathological analysis of different 5-aminolevulinic acid-induced fluorescence levels in newly diagnosed glioblastomas.
    J Neurosurg. 2017 Oct 27:1-13. doi: 10.3171/2017.4.JNS162991.
    PubMed     Text format     Abstract available

  31. ZHENG SH, Huang JL, Chen M, Wang BL, et al
    Diagnostic value of preoperative inflammatory markers in patients with glioma: a multicenter cohort study.
    J Neurosurg. 2017 Nov 3:1-10. doi: 10.3171/2017.3.JNS161648.
    PubMed     Text format     Abstract available


    Neuro Oncol

  32. HAYES J, Yu Y, Jalbert LE, Mazor T, et al
    Genomic analysis of the origins and evolution of multicentric diffuse lower-grade gliomas.
    Neuro Oncol. 2017 Oct 25. doi: 10.1093.
    PubMed     Text format     Abstract available

  33. DEUMELANDT K, Platten M, Ochs K
    Synergy of vaccination and agonist OX40 treatment-toward a mechanism-driven combination of glioma immunotherapy.
    Neuro Oncol. 2017 Oct 28. doi: 10.1093.
    PubMed     Text format    

  34. TENG J, Hejazi S, Hiddingh L, Carvalho L, et al
    Recycling drug screen repurposes hydroxyurea as a sensitizer of glioblastomas to temozolomide targeting de novo DNA synthesis, irrespective of molecular subtype.
    Neuro Oncol. 2017 Nov 1. doi: 10.1093.
    PubMed     Text format     Abstract available

  35. GAN HK, Reardon DA, Lassman AB, Merrell R, et al
    Safety, Pharmacokinetics and Antitumor Response of Depatuxizumab Mafodotin as Monotherapy or in Combination with Temozolomide in Patients with Glioblastoma.
    Neuro Oncol. 2017 Oct 25. doi: 10.1093.
    PubMed     Text format     Abstract available


    Neuroradiology

  36. SAINI J, Gupta PK, Sahoo P, Singh A, et al
    Differentiation of grade II/III and grade IV glioma by combining "T1 contrast-enhanced brain perfusion imaging" and susceptibility-weighted quantitative imaging.
    Neuroradiology. 2017 Oct 31. doi: 10.1007/s00234-017-1942.
    PubMed     Text format     Abstract available


    Neurosurgery

  37. TEJADA S, Alonso M, Patino A, Fueyo J, et al
    Phase I Trial of DNX-2401 for Diffuse Intrinsic Pontine Glioma Newly Diagnosed in Pediatric Patients.
    Neurosurgery. 2017 Oct 27. doi: 10.1093.
    PubMed     Text format     Abstract available

  38. CALAYAG M, Gabel BC, Hong DS, Hatefi D, et al
    197 Considerations in Relationship to the Approach for the Treatment of Lateralized Posterior Fossa Tumors in Children.
    Neurosurgery. 2016;63 Suppl 1:177-8.
    PubMed     Text format     Abstract available

  39. SHAH SR, Tippens N, Park J, Mohyeldin A, et al
    217 YAP Is Ready to Rac and Rho: Elucidation of a Novel YAP-Driven Network That Potentiates Brain Cancer Cell Dispersal and Confers Poor Survival in Patients.
    Neurosurgery. 2016;63 Suppl 1:185.
    PubMed     Text format     Abstract available

  40. HERSH DS, Kim AJ, Winkles JA, Eisenberg HM, et al
    Emerging Applications of Therapeutic Ultrasound in Neuro-oncology: Moving Beyond Tumor Ablation.
    Neurosurgery. 2016.
    PubMed     Text format     Abstract available

  41. SCHNEIDER JR, Kwan K, Boockvar JA
    Use of HER2-Specific Chimeric Antigen Receptor-Modified Virus-Specific T Cells as a Potential Therapeutic for Progressive HER2-Positive Glioblastoma.
    Neurosurgery. 2017;81:N42-N43.
    PubMed     Text format    

  42. EHRLICH NA, Zhang RR, Kuo JS
    Anti-Programmed Cell Death Protein-1 Immunotherapy for Glioblastoma is Impaired by Systemic Chemotherapy but Enhanced in Combination With Locally Delivered Chemotherapy.
    Neurosurgery. 2017;81:N34-N36.
    PubMed     Text format    

  43. ALEXIADES NG, Mckhann GM 2nd
    Getting More Skin in the Game: Using Human Neural Stem Cells Transdifferentiated From Fibroblasts to Target Malignant Gliomas.
    Neurosurgery. 2017;81:N36-N37.
    PubMed     Text format    

  44. OSBORN VW, Lee A, Garay E, Safdieh J, et al
    Impact of Timing of Adjuvant Chemoradiation for Glioblastoma in a Large Hospital Database.
    Neurosurgery. 2017 Oct 28. doi: 10.1093.
    PubMed     Text format     Abstract available


    PLoS One

  45. FAN W, Fan SS, Feng J, Xiao D, et al
    Elevated expression of HSP10 protein inhibits apoptosis and associates with poor prognosis of astrocytoma.
    PLoS One. 2017;12:e0185563.
    PubMed     Text format     Abstract available

  46. MADHU B, Jauhiainen A, McGuire S, Griffiths JR, et al
    Exploration of human brain tumour metabolism using pairwise metabolite-metabolite correlation analysis (MMCA) of HR-MAS 1H NMR spectra.
    PLoS One. 2017;12:e0185980.
    PubMed     Text format     Abstract available

  47. GRENIER JK, Foureman PA, Sloma EA, Miller AD, et al
    RNA-seq transcriptome analysis of formalin fixed, paraffin-embedded canine meningioma.
    PLoS One. 2017;12:e0187150.
    PubMed     Text format     Abstract available

  48. MITRA S, Banerjee S, Hayashi Y
    Volumetric brain tumour detection from MRI using visual saliency.
    PLoS One. 2017;12:e0187209.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  49. ONG DST, Hu B, Ho YW, Sauve CG, et al
    PAF promotes stemness and radioresistance of glioma stem cells.
    Proc Natl Acad Sci U S A. 2017;114:E9086-E9095.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Neoplasms of the CNS is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: